5/16/2023 | BKCVDDEMIGPV | Market Commentary: Junk calendar full, but market waits; Horizon Pharma takes a hit; Newell lower; PGT gains
|
12/12/2022 | BKCVDDEMIGPV | Market Commentary: Secondary firms ahead of CPI, Fed; Chart gains continue; Horizon up on acquisition
|
7/16/2019 | BK | Horizon Pharma USA pays down $100 million of secured term loans
|
7/12/2019 | BKCVDDEMIGPV | Market Commentary: E.W. Scripps prices; TPC joins calendar; Horizon, MTS gain; Olin improves; Masonite lags
|
7/11/2019 | BKCVDDEMIGPV | Market Commentary: Olin, Horizon Pharma, Masonite, MTS Systems, Builders price; funds add $619 million
|
7/10/2019 | BKCVDDEMIGPV | Market Commentary: Melco Resorts, Alight Solutions add-on price; MTS Systems, Horizon Pharma on tap
|
7/10/2019 | BKHY | Moody’s rates Horizon Pharma notes B1
|
7/10/2019 | BKHY | S&P rates Horizon Pharma notes B+
|
5/15/2019 | BK | Fitch cuts Lucid Energy, rates loan BB-
|
5/15/2019 | BKHY | Moody’s rates Horizon Pharma loan Ba1
|
3/20/2019 | BK | Moody's downgrades Advanced Integration
|
3/20/2019 | BKHY | Moody's lifts Horizon Pharma USA
|
3/11/2019 | BK | Horizon Pharma USA gets $200 million of new revolving commitments
|
3/5/2019 | BKCVHY | Moody's may upgrade Horizon
|
10/10/2017 | BK | Market Commentary: First Eagle launches $1.52 billion, UPC $1.6 billion and €500 million
|
10/10/2017 | BK | Horizon Pharma launches $845.75 million repricing of term loan B
|